Translational Medicine Lead - Phase 1/2 (Hybrid)

Healthcare Businesswomen’s Association; Basel; Vor Ort; CHF 123.000 - 228.000; Vollzeit

Benefits dieser Stelle

Insurance plans

Retirement plans

Wellbeing resources

Global recognition programs

Flexible & hybrid working

14 weeks parental leave

Zusammenfassung

Novartis is seeking Translational Medicine Experts (TMEs) to lead phase 1/2 studies and shape early clinical development. You will collaborate with biology, chemistry, and cross-functional teams to design, implement, and oversee early research programs in gastroenterology/IBD, ensuring medical leadership across trials and regulatory interactions.

The role emphasizes independent leadership, scientific expertise, and strong communication to align teams and drive development plans within a hybrid

Qualifikationen

• Medical doctor with board certification in gastroenterology or relevant medical specialty.
• Several years of clinical experience treating IBD (UC and CD) patients.
• Ability to learn fast and work independently.
• Ability to lead multidisciplinary teams in a matrix organization.
• Excellent communication and presentation skills.

Aufgaben

• Lead global clinical trial teams through phase 1 and 2 development
• Draft the early clinical development plan
• Act as medical lead for early clinical studies
• Represent the team in relevant decision boards
• Serve a primary contact for internal and external key opinion leaders
• Oversee publication and internal/external presentation of clinical study results
• Work closely with biomarker experts in implementation
• Collaborate with research scientists to identify, develop and implement strategy for preclinical support of program related objectives
• Actively participate in Health Authority interactions

Kenntnisse

Clinical Trials

Data Analysis

Data Monitoring

Drug Development

People Management

Ausbildung

Medical degree (MD) with board certification in gastroenterology or relevant specialty

Jobbeschreibung

Novartis is seeking Translational Medicine Experts (TMEs) to lead phase 1/2 studies and shape early clinical development. You will collaborate with biology, chemistry, and cross-functional teams to design, implement, and oversee early research programs in gastroenterology/IBD, ensuring medical leadership across trials and regulatory interactions.

The role emphasizes independent leadership, scientific expertise, and strong communication to align teams and drive development plans within a hybrid